News | October 16, 2025
IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
The new data highlight the potential of AstraZeneca’s innovative therapies to improve outcomes across multiple cancer types
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
The pooled prevalence of GERD in the Indian population is 15.6 %
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
The company has received five final approvals
Subscribe To Our Newsletter & Stay Updated
